跳至主要内容
临床试验/IRCT20201110049334N2
IRCT20201110049334N2已完成3 期

The effect of Bisphosphonate diet with and without testosterone on bone density parameters in male patients with major thalassemia

Iran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 no limit(—)
性别
Male

入选标准

  • Patients Consent to participate in the study
  • Male patients with major thalassemia and older than 13.5 years
  • Patients with hypogonadism (based on blood testosterone, LH and FSH levels) and without hypogonadism
  • No concomitant underlying disease (including thyroid disease, parathyroid disease, kidney and liver disease and diabetes)

排除标准

  • Patients with abnormal level of liver enzymes (AST and ALT)
  • Patients with renal disorder
  • Patients with abnormal levels of calcium, blood phosphorus and vitamin D3
  • Patients with abnormal levels of thyroid function hormones and diabetes
  • Patients with abnormal levels of PTH and ALP
  • Patients with bone density greater than -5.2
  • Do not take the drug by the patient until the end of the study

研究者

相似试验

已完成
2 期
Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.Prediabetes.Impaired glucose tolerance, Menopausal and other perimenopausal disorders, Postmenopausal osteoporosisR73, N95,
IRCT2016101530309N1Vice chancellor for research, Isfahan University of Medical Sciences60
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuria
ISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
招募中
不适用
The Effect of Bisphosphonates on the Immune System in Adults With OsteoporosisImmune systemMusculoskeletal - OsteoporosisInflammatory and Immune System - Other inflammatory or immune system disordersOsteoporosis
ACTRN12614000300673Bone Research Group, Garvan Institute of Medical Research44
已完成
不适用
The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)Ankylosing Spondylitis (AS)Musculoskeletal Diseases
ISRCTN87639321Royal National Hospital for Rheumatic Diseases (UK)180
进行中(未招募)
1 期
Brittle bones - do they react normally after treatment with bisphosphonates?Osteogenesis ImperfectaMedDRA version: 19.0Level: PTClassification code 10031243Term: Osteogenesis imperfectaSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2016-003606-14-GBSheffield Children's NHS Foundation Trust15